Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Asis Shrestha

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOM | Internal Med Hem-Onc
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0000-0003-2411-0514 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M. Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies. Br J Haematol. 2024 Aug 27. PMID: 39192546.
      View in: PubMed
    2. Naqvi S, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem. 2024 Aug; 5(4):789-792. PMID: 39157593.
      View in: PubMed
    3. Miller K, Stawderman MS, Niraula S, Babbra R, Neupane N, Shrestha A, Gouli S, Kharel Z, Carey K,A, Mohile N, O’Regan R, Falkson CI, Weiss A, Mgnsuson A, Stanford S, Dhakal A. . Journal of Clinical Oncology. Effect of the timing of recurrence on survival among patients with breast cancer with brain metastasis. 2024; 42(16 suppl):e14005.
      View Publication
    4. Naqvi SM, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Talquetamab (Tal) therapy in relapsed/refractory (R/R) multiple myeloma (MM): Assessing weight loss and dysgeusia. Journal of Clinical Oncology. 2024.
      View Publication
    5. Shrestha A, Alzubi M, Alrawabdeh J, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Al Hadidi S. B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma. EJHaem. 2024 Jun; 5(3):554-559. PMID: 38895072.
      View in: PubMed
    6. Trikannad AK, Shrestha A, Vellanki S, Cheema HI, Patel TH, Bachu R, Sharma S, Jeffus SK, Thanendrarajan S. Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm. Cureus. 2024 Jan; 16(1):e53074. PMID: 38414681.
      View in: PubMed
    7. Shrestha J, Shrestha A, Karki P, Dhakal A. Leptomeningeal Disease as an Initial Presenting Manifestation in Breast Cancer. Cureus. 2021 Nov; 13(11):e19666. PMID: 34956772.
      View in: PubMed
    8. Shrestha A, Bischof E. Crusted Scabies Induced Hypereosinophilic Syndrome. Cureus. 2021 May 23; 13(5):e15201. PMID: 34178521.
      View in: PubMed
    Co-Authors Expand Description
    See all (10) people
    _
    Same Department Expand Description
    Search Department